The illustrations in Figure 3, Figure 4 and Figure 5 collectively highlight the prognostic and predictive roles of PTEN, RB1, and TP53 gene alterations, respectively, across prostate cancer stages, emphasizing their influence on treatment sensitivity, resistance mechanisms, and survival outcomes. The gene discussed is RB1; the disease is Familial prostate cancer.